Edward M. Kaye MD - 05 Aug 2022 Form 4 Insider Report for CYTOKINETICS INC (CYTK)

Role: Director
Signature: /s/ John Faurescu, attorney-in-fact for Dr. Kaye
Issuer symbol: CYTK
Transactions as of: 05 Aug 2022
Net transactions value: -$471,405
Form type: 4
Filing time: 08 Aug 2022, 16:01:04 UTC
Previous filing: 12 Jul 2022
Next filing: 05 Oct 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CYTK	Common Stock	Options Exercise	$99,995	+11,428	+91%	$8.75	24,004	05 Aug 2022	Direct	F1
transaction	CYTK	Common Stock	Sale	$571,400	-11,428	-48%	$50.00	12,576	05 Aug 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CYTK	Non-Qualified Stock Option (Right to Buy)	Options Exercise	$0	-11,428	-100%	$0.000000^*	0	05 Aug 2022	Common Stock	11,428	$8.75	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on November 12, 2021.